Cargando…
Favorable Outcome of COVID-19 Pneumonia in a Kidney Transplant Recipient Treated with Tocilizumab
The presentation of COVID-19 pneumonia in kidney transplant recipients is similar to that of the general population. However, in the former, it may have a worse clinical course. We report a kidney transplant patient affected by COVID-19 pneumonia whose condition worsened 9 days after the initial pre...
Autores principales: | Guella, Adnane, Elfadil, Osman, Abdulrazaq, Ghisson, Osman, Sahla, Khan, Mohammed Munir, Ahmed, Abdalla, Deyab, Feras |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495166/ https://www.ncbi.nlm.nih.gov/pubmed/32963854 http://dx.doi.org/10.1155/2020/8830626 |
Ejemplares similares
-
Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab
por: Gautier-Vargas, Gabriela, et al.
Publicado: (2020) -
Favorable Outcomes in Older Recipients Receiving Simultaneous Pancreas Kidney Transplantation
por: Budhiraja, Pooja, et al.
Publicado: (2022) -
Limitations of the Karnofsky Performance Status Scale in kidney transplant recipients
por: Daoud, Ahmed Mahmoud Osman, et al.
Publicado: (2022) -
Efficacy and Safety of Tocilizumab in the Treatment of Acute Active Antibody-mediated Rejection in Kidney Transplant Recipients
por: Pottebaum, April A., et al.
Publicado: (2020) -
Elderly kidney transplant recipients have favorable outcomes but increased infection-related mortality
por: Lim, Jeong-Hoon, et al.
Publicado: (2022)